Skip to main content

September/October 2023

Featured Article

Clinical Pathways GPS
09/19/2023
Richard G. Stefanacci, DO, discusses the important role retired physicians play as patient navigators, with a focus on oncology care.
Richard G. Stefanacci, DO, discusses the important role retired physicians play as patient navigators, with a focus on oncology care.
Richard G. Stefanacci, DO,...
09/19/2023
Journal of Clinical Pathways
Editor's Page
09/19/2023
Editor-in-Chief Winston Wong, PharmD, provides insights on this issue’s content, highlighting the latest scientific developments in genetic testing for oncology biomarkers into clinical care.
Editor-in-Chief Winston Wong, PharmD, provides insights on this issue’s content, highlighting the latest scientific developments in genetic testing for oncology biomarkers into clinical care.
Editor-in-Chief Winston Wong,...
09/19/2023
Journal of Clinical Pathways
Research Reports
09/19/2023
Julie Wiedower, PhDc, and colleagues analyze the frequency of real-world off-label therapy utilization post–comprehensive genomic profiling via liquid biopsy in precision oncology.
Julie Wiedower, PhDc, and colleagues analyze the frequency of real-world off-label therapy utilization post–comprehensive genomic profiling via liquid biopsy in precision oncology.
Julie Wiedower, PhDc, and...
09/19/2023
Journal of Clinical Pathways

Column

COA Viewpoint
09/19/2023
Nicolas Ferreyros discusses the impact, or the lack of impact, the launch of the Enhancing Oncology Model has had on practices.
Nicolas Ferreyros discusses the impact, or the lack of impact, the launch of the Enhancing Oncology Model has had on practices.
Nicolas Ferreyros discusses the...
09/19/2023
Journal of Clinical Pathways
Transformative Employer Trends
09/19/2023
This installment of the Transformative Employer Trends column further explores ways to address access to gene and cell therapies that are transforming management of benefits by employer plans.
This installment of the Transformative Employer Trends column further explores ways to address access to gene and cell therapies that are transforming management of benefits by employer plans.
This installment of the...
09/19/2023
Journal of Clinical Pathways
MAI Mindset
09/19/2023
In this first entry of our new MAI Mindset column, Lee Blansett, MBA, provides an overview of how in addition to providing benefits, clinical pathways can also present challenges and potential risks for manufacturers.
In this first entry of our new MAI Mindset column, Lee Blansett, MBA, provides an overview of how in addition to providing benefits, clinical pathways can also present challenges and potential risks for manufacturers.
In this first entry of our new...
09/19/2023
Journal of Clinical Pathways
Trending From ACCC
09/19/2023
Association of Community Cancer Centers
This column describes the findings from the 2022 Association of Community Cancer Centers (ACCC) patient survey to identify challenges and benefits associated with wearable devices and other digital tools.
This column describes the findings from the 2022 Association of Community Cancer Centers (ACCC) patient survey to identify challenges and benefits associated with wearable devices and other digital tools.
This column describes the...
09/19/2023
Journal of Clinical Pathways

Feature

OCPC: IN SESSION
09/19/2023
Mathew Biancalana, PhD, and Tushar Pandey, MBA, discuss how artificial intelligence can enhance the field of precision medicine and help unburden physicians from laborious and repetitive tasks in diagnostic analyses.
Mathew Biancalana, PhD, and Tushar Pandey, MBA, discuss how artificial intelligence can enhance the field of precision medicine and help unburden physicians from laborious and repetitive tasks in diagnostic analyses.
Mathew Biancalana, PhD, and...
09/19/2023
Journal of Clinical Pathways
Review
09/19/2023
Winston Wong, PharmD, and Gordon Kuntz provide an update on the current status of the research and barriers for using next-generation sequencing in NSCLC and summarize the discussion and next steps that the NGS Institute’s NSCLC Subcommittee...
Winston Wong, PharmD, and Gordon Kuntz provide an update on the current status of the research and barriers for using next-generation sequencing in NSCLC and summarize the discussion and next steps that the NGS Institute’s NSCLC Subcommittee...
Winston Wong, PharmD, and Gordon...
09/19/2023
Journal of Clinical Pathways

Department

Clinical Pathways Forum
09/19/2023
For the May 2023 Clinical Pathways Forum, Suzzette Arnal, PhD, addressed the Forum about precision medicine and how The US Oncology Network has worked to increase precision medicine testing across their organization.
For the May 2023 Clinical Pathways Forum, Suzzette Arnal, PhD, addressed the Forum about precision medicine and how The US Oncology Network has worked to increase precision medicine testing across their organization.
For the May 2023 Clinical...
09/19/2023
Journal of Clinical Pathways